Review program extended until end of 2030
Important Regulatory Update for Biocidal Active Substances
The European Commission has issued Delegated Regulation (EU) 2024/1398, amending Regulation (EU) No 528/2012. This update extends the review program for all existing biocidal active substances until December 31, 2030.
Key Points:
- Extended Deadline: The systematic examination of active substances contained in biocidal products will now run until the end of 2030 instead of the end of 2024.
- Why the delay? Challenges include limited resources, complex technical issues, and new scientific criteria for endocrine disruptors.
- Compliance: Ensure your compliance processes are updated to align with these changes.
🔍 Impact: This extension aims to ensure thorough evaluation, improving safety and environmental protection standards.
More Important Deadlines:
- Member states must request missing data on endocrine effects by June 30, 2024.
- Applicants have until December 31, 2026, to submit this data.
- Post-2026, evaluations will proceed based on submitted data or face rejection.
📅 Effective Date: June 11, 2024
If you need assistance with your regulatory challenges, please contact our experienced team!